Frolov V M, Petrunia A M, Pinskiĭ L L
Lik Sprava. 1996 Jul-Sep(7-9):84-6.
Pathogenetic role was studied of NIF in patients with viral hepatitides (VH) A, B and C, as well as chronic hepatitis such as persisting (ChPH) and active (ChAH) HBsAg+. It has been ascertained that under evolving chronic pathology of the liver in terminating acute VH, NIF tends to rise, which observation is compatible with clinical and laboratory signs of chronization of the pathological process in the liver. In ChAH and hepatocirrhosis (HC) during the phase of exacerbation major proportions of patient populations demonstrate lowering of NIF levels as evidenced by low values for the antibody inhibition reaction. Compensated HC is is associated with an elevated index of inhibition (II), which observation is accompanied by improvement of parameters associated with the immune response. Pathogenetic significance of NIF per mit adopting differentiated therapy with immunocorrecting drugs taking into account the level of the parameter in question.
研究了NIF在甲型、乙型和丙型病毒性肝炎(VH)以及慢性肝炎患者中的致病作用,这些慢性肝炎包括持续性(ChPH)和活动性(ChAH)HBsAg阳性的慢性肝炎。已确定,在急性VH末期肝脏慢性病理演变过程中,NIF趋于升高,这一观察结果与肝脏病理过程慢性化的临床和实验室体征相符。在ChAH和肝硬化(HC)的加重期,大部分患者群体的NIF水平降低,抗体抑制反应值较低证明了这一点。代偿性HC与抑制指数(II)升高相关,这一观察结果伴随着与免疫反应相关参数的改善。考虑到该参数水平,NIF在采用免疫纠正药物进行分化治疗中的致病意义。